These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3027696)

  • 1. Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
    Lemaitre M; Bayard B; Lebleu B
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):648-52. PubMed ID: 3027696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides.
    Leonetti JP; Rayner B; Lemaitre M; Gagnor C; Milhaud PG; Imbach JL; Lebleu B
    Gene; 1988 Dec; 72(1-2):323-32. PubMed ID: 2854089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA.
    Degols G; Leonetti JP; Gagnor C; Lemaitre M; Lebleu B
    Nucleic Acids Res; 1989 Nov; 17(22):9341-50. PubMed ID: 2479915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.
    Leonetti JP; Degols G; Lebleu B
    Bioconjug Chem; 1990; 1(2):149-53. PubMed ID: 1965625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
    Bayard B; Bisbal C; Lebleu B
    Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.
    Prasad V; Hashim S; Mukhopadhyay A; Basu SK; Roy RP
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2689-96. PubMed ID: 10543748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.
    Leonetti JP; Machy P; Degols G; Lebleu B; Leserman L
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2448-51. PubMed ID: 2157200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of exonuclease-resistant, psoralen-conjugated oligodeoxyribonucleotides in vitro and in cell culture.
    Levis JT; Miller PS
    Antisense Res Dev; 1994; 4(4):231-41. PubMed ID: 7734938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates.
    Agris CH; Blake KR; Miller PS; Reddy MP; Ts'o PO
    Biochemistry; 1986 Oct; 25(20):6268-75. PubMed ID: 3024704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5' sequence of vesicular stomatitis virus N-gene confers selective translation of mRNA.
    Berg DT; Grinnell BW
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1585-90. PubMed ID: 1336374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter analysis of the vesicular stomatitis virus RNA polymerase.
    Smallwood S; Moyer SA
    Virology; 1993 Jan; 192(1):254-63. PubMed ID: 8390755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nucleocapsid protein of vesicular stomatitis virus isolated from the brains of nude mice is responsible for abated viral RNA synthesis at the normal body temperature of mice.
    Doll SC; Johnson TC
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():29-36. PubMed ID: 2154537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis in vitro of full length genomic RNA and assembly of the nucleocapsid of vesicular stomatitis virus in a coupled transcription-translation system.
    Ghosh K; Ghosh HP
    Nucleic Acids Res; 1982 Oct; 10(20):6341-51. PubMed ID: 6294600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular distribution of microinjected antisense oligonucleotides.
    Leonetti JP; Mechti N; Degols G; Gagnor C; Lebleu B
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2702-6. PubMed ID: 1849273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of the prostanoid clavulone II against vesicular stomatitis virus.
    Bader T; Yamada Y; Ankel H
    Antiviral Res; 1991 Dec; 16(4):341-55. PubMed ID: 1663734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates.
    Shea RG; Marsters JC; Bischofberger N
    Nucleic Acids Res; 1990 Jul; 18(13):3777-83. PubMed ID: 2165251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptionally defective nucleocapsids of vesicular stomatitis virus from cells treated with indomethacin.
    Mukherjee PK; Simpson RW
    Virology; 1987 Jan; 156(1):25-31. PubMed ID: 3027967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.
    Ostertag D; Hoblitzell-Ostertag TM; Perrault J
    J Virol; 2007 Jan; 81(2):503-13. PubMed ID: 17065213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete sequence of the major nucleocapsid protein gene of human parainfluenza type 3 virus: comparison with other negative strand viruses.
    Jambou RC; Elango N; Venkatesan S; Collins PL
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2543-8. PubMed ID: 2878059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.